Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Environ Res. 2019 Feb 22;172:430–436. doi: 10.1016/j.envres.2019.02.034

Table 1:

Demographic characteristics of the 30 men contributing 60 urine samples in MARS by crossover arm.

Baseline characteristics, men (N)a B1H-arm (15 men, 30 samples) H1B-arm (15 men, 30 samples) Total (30 men, 60 samples) P-value b
Age (Years) 35.2 (8.63) 34.5 (10.8) 34.8 (9.60) 0.63
Race 0.35
 Caucasian 14 (93) 12 (80) 26 (87) -
 Black/African American 1 (7) 0 1 (3) -
 Asian 0 1 (7) 1 (3) -
 Other 0 2 (13) 2 (7) -
BMI (Kg/m2) 26.6 (3.68) 24.3 (3.23) 25.5 (3.59) 0.08
BMI-categories 0.15
 Normal weight 5 (33) 9 (60) 14 (47) -
 Overweight 7 (47) 6 (40) 13 (43) -
 Obese 3 (20) 0 3 (10) -
Education 0.26
 Below college 0 2 (14) 2 (7) -
 College graduate 9 (69) 6 (43) 15 (56) -
 Graduate degree 4 (31) 6 (43) 10 (37) -
Smoking status 0.99
 Never smoker 14 (93) 14 (93) 28 (93) -
 Former smoker 1 (7) 1 (7) 2 (7) -
 Current smoker 0 0 0 -
IBD diagnosis 0.99
 Ulcerative colitis 11 (73) 10 (67) 21 (70) -
 Crohn’s disease 4 (27) 5 (33) 9 (30) -
IBD scored 1.8 (1.42) 0.93 (1.44) 1.37 (1.47) 0.07
Duration since IBD diagnosis (years) 10.5 (8.15) 10.5 (7.50) 10.5 (7.70) 0.95
Alcohole 0.07
 < 1 days/week 5 (36) 8 (57) 13 (46) -
 1–2 days/week 8 (57) 2 (14) 10 (36) -
 ≥2 days/week 1 (7) 4 (29) 5 (18) -
Time-varying characteristics, Samples (n)a
Warm season of urine sample c 11 (37) 17 (57) 28 (47) 0.12
Fever in last 3 months 1 (3) 0 1 (2) 0.99
Illness in last 3 months 9 (33) 4 (15) 13 (25) 0.20

Abbreviations: MARS, Mesalamine And Reproductive health Study; DBP, dibutyl phthalate; BMI, body mass index; Kg, Kilogram; m, meter; SD, standard deviation; IBD, Inflammatory Bowel Disease; UC, ulcerative colitis; CD, Crohn’s disease; N; number of men, CI; confidence interval.

B1H-arm: B1 represents background-exposure of DBP at baseline and H represents high-DBP exposure after crossover. H1B-arm: H1 represents high-DBP exposure at baseline and B represents background-exposure after crossover.

B1H arm: men at baseline were on Liald (N=10), Pentasa (N=4) and Apriso (N=1).

H1B arm: men at baseline were on Asacol (N=7), and Asacol-HD (N=8).

IBD score: included bowel frequency and urgency, presence of blood in the stool and general wellbeing. Mild IBD score: 5 or less on the simple clinical colitis activity index for UC and 4 or less on the Harvey-Bradshaw index for CD.

Season of sample collection, Warm: April through September.

3 missing education, 2 missing alcohol, 1 missing alcohol, and 7 missing illness in the last 3 months.

N (%) for categorical/binary variables and mean (SD) for continuous variables.

P-values are based on Fisher exact test for categorical variables and Kruskal Wallis test for continuous variables.